Humana (NYSE:HUM) Shares Down 4.7%

Humana Inc. (NYSE:HUM)’s share price dropped 4.7% on Wednesday . The company traded as low as $311.58 and last traded at $312.63. Approximately 1,250,091 shares traded hands during trading, a decline of 37% from the average daily volume of 1,976,503 shares. The stock had previously closed at $327.98.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research reports. Wells Fargo & Company dropped their price target on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Truist Financial restated a “hold” rating and issued a $550.00 target price on shares of Humana in a research report on Friday, January 19th. Argus cut Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. StockNews.com cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Finally, Bank of America restated a “neutral” rating and issued a $342.00 target price (down from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $433.74.

Humana Trading Down 0.1 %

The firm has a market cap of $37.52 billion, a price-to-earnings ratio of 19.39, a PEG ratio of 1.85 and a beta of 0.45. The company has a 50-day moving average price of $328.56 and a 200 day moving average price of $395.71. The company has a quick ratio of 1.59, a current ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping the consensus estimate of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana’s revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the firm posted $9.38 earnings per share. As a group, research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.14%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Insider Buying and Selling

In other news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the acquisition, the director now owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.32% of the stock is owned by corporate insiders.

Institutional Trading of Humana

Hedge funds and other institutional investors have recently modified their holdings of the company. Morgan Stanley increased its stake in shares of Humana by 6.2% in the third quarter. Morgan Stanley now owns 2,040,896 shares of the insurance provider’s stock worth $992,938,000 after purchasing an additional 119,760 shares during the period. Ameriprise Financial Inc. grew its position in Humana by 35.9% during the third quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after buying an additional 402,559 shares in the last quarter. Norges Bank acquired a new stake in Humana during the fourth quarter worth about $676,800,000. Northern Trust Corp boosted its holdings in Humana by 5.1% during the third quarter. Northern Trust Corp now owns 1,327,489 shares of the insurance provider’s stock valued at $645,850,000 after purchasing an additional 64,245 shares in the last quarter. Finally, Sanders Capital LLC acquired a new stake in Humana during the fourth quarter valued at approximately $489,300,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.